Laura Brege

(Ms. Laura Brege)

Currently holds positions in ACADIA Pharmaceuticals Inc, Pacira Biosciences Inc and Portola Pharmaceuticals Inc

Positions
Position Company Period
Independent Director ACADIA Pharmaceuticals Inc May 1, 2008 -
Independent Director Pacira Biosciences Inc June 2, 2011 -
Independent Director Portola Pharmaceuticals Inc Jan. 27, 2015 -
Independent Director Dynavax Technologies Corp Feb. 6, 2015 - Feb. 13, 2020
Independent Director Aratana Therapeutics Inc Feb. 5, 2014 - March 14, 2019
Independent Director Delcath Systems Inc July 5, 2012 - Dec. 11, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-06-14 2023-06-12
PS Planned sale
4,500 -25.0%
24.87
111,906 USD 		4,500 -25.0% 24.87 111,906 USD
2023-06-07 2023-06-05
PS Planned sale
600 -5.9%
38.74
23,244 USD 		600 -5.9% 38.74 23,244 USD
2023-04-05 2023-04-03
PS Planned sale
7,000 -40.8%
40.72
285,040 USD 		7,000 -40.8% 40.72 285,040 USD
2023-01-17 2023-01-12
PS Planned sale
12,500 -100.0%
18.25
228,125 USD 		12,500 -100.0% 18.25 228,125 USD
2020-11-17 2020-11-16
S Sale
12,000 -60.2%
65.95
791,400 USD 		12,000 -60.2% 65.95 791,400 USD
2020-06-08 2020-06-05
S Sale
2,100 -24.0%
48.70
102,270 USD 		2,100 -24.0% 48.70 102,270 USD
2020-01-08 2020-01-07
PS Planned sale
10,000 -100.0%
42.19
421,900 USD 		10,000 -100.0% 42.19 421,900 USD
2019-09-12 2019-09-10
B Purchase
10,000 +inf%
11.22
112,200 USD 		10,000 +inf% 11.22 112,200 USD
2019-01-11 2019-01-09
PS Planned sale
10,000 -100.0%
20.00
200,041 USD 		10,000 -100.0% 20.00 200,041 USD
2016-06-08 2016-06-06
PS Planned sale
1,000 -50.0%
46.95
46,950 USD 		1,000 -50.0% 46.95 46,950 USD